Integrated genomics of susceptibility to alkylator-induced leukemia in mice

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Cahan, Patrick ^a   Graubert, Timothy A ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CANCER SUSCEPTIBILITY; COPY NUMBER VARIATION; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE MAP; HEMATOPOIETIC STEM CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; THERAPY RELATED ACUTE MYELOID LEUKEMIA; ANIMAL; CHEMICALLY INDUCED DISORDER; CLUSTER ANALYSIS; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; GENOMICS; HAPLOTYPE; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE STRAIN; PATHOLOGY; QUANTITATIVE TRAIT LOCUS; STATISTICS; TUMOR CELL LINE; TUMOR GENE;

MUS;

ALKYLATING AGENTS; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REGULATORY NETWORKS; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HAPLOTYPES; HEMATOPOIETIC STEM CELLS; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; QUANTITATIVE TRAIT LOCI; STATISTICS AS TOPIC; TRANSCRIPTION, GENETIC;

EID: 78249235926     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-638     Document Type: Article

References (61)

1. Leone G, Voso MT, Sica S, Morosetti R, Pagano L. Therapy related leukemias: susceptibility, prevention and treatment. Leuk Lymphoma 2001, 41(3-4):255-276. 10.3109/10428190109057981, 11378539.
2. Leone G, Pagano L, Ben-Yehuda D, Voso MT. Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 2007, 92(10):1389-1398. 10.3324/haematol.11034, 17768113.
3. Larson RA, Le Beau MM. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans. Chem Biol Interact 2005, 153-154:187-195. 10.1016/j.cbi.2005.03.023, 15935816.
4. Knoche E, Mc Leod HL, Graubert TA. Pharmacogenetics of alkylator-associated acute myeloid leukemia. Pharmacogenomics 2006, 7(5):719-729. 10.2217/14622416.7.5.719, 16886897.
5. Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M, Shannon K. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 1997, 336(24):1713-1720. 10.1056/NEJM199706123362404, 9180088.
6. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 1994, 7(3):353-361. 10.1038/ng0794-353, 7920653.
7. Meikrantz W, Bergom MA, Memisoglu A, Samson L. O6-alkylguanine DNA lesions trigger apoptosis. Carcinogenesis 1998, 19(2):369-372. 10.1093/carcin/19.2.369, 9498291.
8. Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 2002, 100(10):3761-3766. 10.1182/blood-2002-04-1152, 12393447.
9. Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, Roddam PL, Roman E, Cartwright RA, Morgan GJ. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci USA 2001, 98(20):11592-11597. 10.1073/pnas.191211198, 58774, 11553769.
10. Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT. Prevalence of the inactivating 609C--T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999, 94(2):803-807.
11. Fenske TS, Mc Mahon C, Edwin D, Jarvis JC, Cheverud JM, Minn M, Mathews V, Bogue MA, Province MA, McLeod HL, et al. Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice. Cancer Res 2006, 66(10):5029-5038. 10.1158/0008-5472.CAN-05-3404, 16707424.
12. Noveroske JK, Weber JS, Justice MJ. The mutagenic action of N-ethyl-N-nitrosourea in the mouse. Mamm Genome 2000, 11(7):478-483. 10.1007/s003350010093, 10886009.
13. Thirman MJ, Larson RA. Therapy-related myeloid leukemia. Hematol Oncol Clin North Am 1996, 10(2):293-320. 10.1016/S0889-8588(05)70340-3, 8707757.
14. Birrell GW, Brown JA, Wu HI, Giaever G, Chu AM, Davis RW, Brown JM. Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents. Proc Natl Acad Sci USA 2002, 99(13):8778-8783. 10.1073/pnas.132275199, 124375, 12077312.
15. Fry RC, Svensson JP, Valiathan C, Wang E, Hogan BJ, Bhattacharya S, Bugni JM, Whittaker CA, Samson LD. Genomic predictors of interindividual differences in response to DNA damaging agents. Genes Dev 2008, 22(19):2621-2626. 10.1101/gad.1688508, 2559901, 18805990.
16. Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature 2009, 461(7261):218-223. 10.1038/nature08454, 19741703.
17. Meng H, Vera I, Che N, Wang X, Wang SS, Ingram-Drake L, Schadt EE, Drake TA, Lusis AJ. Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc Natl Acad Sci USA 2007, 104(11):4530-4535. 10.1073/pnas.0607620104, 1838635, 17360558.
18. Wang SS, Shi W, Wang X, Velky L, Greenlee S, Wang MT, Drake TA, Lusis AJ. Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice. Arterioscler Thromb Vasc Biol 2007, 27(12):2671-2676. 10.1161/ATVBAHA.107.148106, 17916774.
19. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo V, Ruff TG, Milligan SB, Lamb JR, Cavet G, et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003, 422(6929):297-302. 10.1038/nature01434, 12646919.
20. Schadt EE, Lamb J, Yang X, Zhu J, Edwards S, Guhathakurta D, Sieberts SK, Monks S, Reitman M, Zhang C, et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 2005, 37(7):710-717. 10.1038/ng1589, 2841396, 15965475.
21. Yang X, Deignan JL, Qi H, Zhu J, Qian S, Zhong J, Torosyan G, Majid S, Falkard B, Kleinhanz RR, et al. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat Genet 2009, 41(4):415-423. 10.1038/ng.325, 2837947, 19270708.
22. Ghazalpour A, Doss S, Zhang B, Wang S, Plaisier C, Castellanos R, Brozell A, Schadt EE, Drake TA, Lusis AJ, et al. Integrating genetic and network analysis to characterize genes related to mouse weight. PLoS Genet 2006, 2(8):-e130. 10.1371/journal.pgen.0020130, 1550283, 16934000.
23. Plaisier CL, Horvath S, Huertas-Vazquez A, Cruz-Bautista I, Herrera MF, Tusie-Luna T, Aguilar-Salinas C, Pajukanta P. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia. PLoS Genet 2009, 5(9):-e1000642. 10.1371/journal.pgen.1000642, 2730565, 19750004.
24. Cahan P, Li Y, Izumi M, Graubert TA. The impact of copy number variation on local gene expression in mouse hematopoietic stem and progenitor cells. Nat Genet 2009, 41(4):430-437. 10.1038/ng.350, 2728431, 19270704.
25. Bogue MA, Grubb SC, Maddatu TP, Bult CJ. Mouse Phenome Database (MPD). Nucleic Acids Res 2007, (35 Database):D643-649. 10.1093/nar/gkl1049, 1781116, 17151079.
26. Cahan P, Godfrey LE, Eis PS, Richmond TA, Selzer RR, Brent M, Mc Leod HL, Ley TJ, Graubert TA. wuHMM: a robust algorithm to detect DNA copy number variation using long oligonucleotide microarray data. Nucleic Acids Res 2008, 36(7):-e41. 10.1093/nar/gkn110, 2367727, 18334530.
27. Nadler JJ, Zou F, Huang H, Moy SS, Lauder J, Crawley JN, Threadgill DW, Wright FA, Magnuson TR. Large-scale gene expression differences across brain regions and inbred strains correlate with a behavioral phenotype. Genetics 2006, 174(3):1229-1236. 10.1534/genetics.106.061481, 1667050, 16980393.
28. Breitling R, Li Y, Tesson BM, Fu J, Wu C, Wiltshire T, Gerrits A, Bystrykh LV, de Haan G, Su AI, et al. Genetical genomics: spotlight on QTL hotspots. PLoS Genet 2008, 4(10):-e1000232.
29. Gerrits A, Li Y, Tesson BM, Bystrykh LV, Weersing E, Ausema A, Dontje B, Wang X, Breitling R, Jansen RC, et al. Expression quantitative trait loci are highly sensitive to cellular differentiation state. PLoS Genet 2009, 5(10):-e1000692. 10.1371/journal.pgen.1000692, 2757904, 19834560.
30. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005, 4. Article17.
31. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9:-559. 10.1186/1471-2105-9-559, 2631488, 19114008.
32. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, Ingle CE, Dunning M, Flicek P, Koller D, et al. Population genomics of human gene expression. Nat Genet 2007, 39(10):1217-1224. 10.1038/ng2142, 2683249, 17873874.
33. Visel A, Zhu Y, May D, Afzal V, Gong E, Attanasio C, Blow MJ, Cohen JC, Rubin EM, Pennacchio LA. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464(7287):409-412. 10.1038/nature08801, 2938076, 20173736.
34. Mc Carroll SA, Kuruvilla FG, Korn JM, Cawley S, Nemesh J, Wysoker A, Shapero MH, de Bakker PI, Maller JB, Kirby A, et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 2008, 40(10):1166-1174. 10.1038/ng.238, 18776908.
35. Young LC, Peters AC, Maeda T, Edelmann W, Kucherlapati R, Andrew SE, Tron VA. DNA mismatch repair protein Msh6 is required for optimal levels of ultraviolet-B-induced apoptosis in primary mouse fibroblasts. J Invest Dermatol 2003, 121(4):876-880. 10.1046/j.1523-1747.2003.12486.x, 14632208.
36. Roos WP, Christmann M, Fraser ST, Kaina B. Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O(6)-methylguanine due to high E2F1 regulated mismatch repair. Cell Death Differ 2007, 14(8):1422-1432. 10.1038/sj.cdd.4402136, 17464330.
37. Klapacz J, Meira LB, Luchetti DG, Calvo JA, Bronson RT, Edelmann W, Samson LD. O6-methylguanine-induced cell death involves exonuclease 1 as well as DNA mismatch recognition in vivo. Proc Natl Acad Sci USA 2009, 106(2):576-581. 10.1073/pnas.0811991106, 2613938, 19124772.
38. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998, 94(3):339-352. 10.1016/S0092-8674(00)81477-4, 9708736.
39. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P, Flavell RA. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998, 94(3):325-337. 10.1016/S0092-8674(00)81476-2, 9708735.
40. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 2002, 419(6907):634-637. 10.1038/nature01101, 12374983.
41. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW, et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 2009, 10(11):R130. 10.1186/gb-2009-10-11-r130, 19919682.
42. Seki A, Fang G. CKAP2 is a spindle-associated protein degraded by APC/C-Cdh1 during mitotic exit. J Biol Chem 2007, 282(20):15103-15113. 10.1074/jbc.M701688200, 17376772.
43. Hong KU, Kim HJ, Kim HS, Seong YS, Hong KM, Bae CD, Park J. Cdk1-cyclin B1-mediated phosphorylation of tumor-associated microtubule-associated protein/cytoskeleton-associated protein 2 in mitosis. J Biol Chem 2009, 284(24):16501-16512. 10.1074/jbc.M900257200, 2713551, 19369249.
44. Jeon SM, Choi B, Hong KU, Kim E, Seong YS, Bae CD, Park J. A cytoskeleton-associated protein, TMAP/CKAP2, is involved in the proliferation of human foreskin fibroblasts. Biochem Biophys Res Commun 2006, 348(1):222-228. 10.1016/j.bbrc.2006.07.046, 16876122.
45. Schreiber V, Ame JC, Dolle P, Schultz I, Rinaldi B, Fraulob V, Menissier-de Murcia J, de Murcia G. Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem 2002, 277(25):23028-23036. 10.1074/jbc.M202390200, 11948190.
46. Raffoul JJ, Cabelof DC, Nakamura J, Meira LB, Friedberg EC, Heydari AR. Apurinic/apyrimidinic endonuclease (APE/REF-1) haploinsufficient mice display tissue-specific differences in DNA polymerase beta-dependent base excision repair. J Biol Chem 2004, 279(18):18425-18433. 10.1074/jbc.M313983200, 14973123.
47. Yang H, Ding Y, Hutchins LN, Szatkiewicz J, Bell TA, Paigen BJ, Graber JH, de Villena FP, Churchill GA. A customized and versatile high-density genotyping array for the mouse. Nat Methods 2009, 6(9):663-666. 10.1038/nmeth.1359, 2735580, 19668205.
48. Sudbery I, Stalker J, Simpson JT, Keane T, Rust AG, Hurles ME, Walter K, Lynch D, Teboul L, Brown SD, et al. Deep short-read sequencing of chromosome 17 from the mouse strains A/J and CAST/Ei identifies significant germline variation and candidate genes that regulate liver triglyceride levels. Genome Biol 2009, 10(10):R112. 10.1186/gb-2009-10-10-r112, 2784327, 19825173.
49. Quinlan AR, Clark RA, Sokolova S, Leibowitz ML, Zhang Y, Hurles ME, Mell JC, Hall IM. Genome-wide mapping and assembly of structural variant breakpoints in the mouse genome. Genome Res
50. Rousseeuw PJ, Kaufman L. Finding Groups in Data: An Introduction to Cluster Analysis. 1990, New York: Wiley.
51. Szatkiewicz JP, Beane GL, Ding Y, Hutchins L, Pardo-Manuel de Villena F, Churchill GA. An imputed genotype resource for the laboratory mouse. Mamm Genome 2008, 19(3):199-208. 10.1007/s00335-008-9098-9, 2725522, 18301946.
52. Zhao H, Nettleton D, Dekkers JC. Evaluation of linkage disequilibrium measures between multi-allelic markers as predictors of linkage disequilibrium between single nucleotide polymorphisms. Genet Res 2007, 89(1):1-6. 10.1017/S0016672307008634, 17517154.
53. Smyth GK. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. New York: Springer, R Gentleman VC, Dudoit S, Irizarry R, Huber W.
54. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3. Article3.
55. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003, 100(16):9440-9445. 10.1073/pnas.1530509100, 170937, 12883005.
56. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57. 10.1038/nprot.2008.211, 19131956.
57. Mc Clurg P, Janes J, Wu C, Delano DL, Walker JR, Batalov S, Takahashi JS, Shimomura K, Kohsaka A, Bass J, et al. Genomewide association analysis in diverse inbred mice: power and population structure. Genetics 2007, 176(1):675-683. 10.1534/genetics.106.066241, 1893038, 17409088.
58. Pletcher MT, Mc Clurg P, Batalov S, Su AI, Barnes SW, Lagler E, Korstanje R, Wang X, Nusskern D, Bogue MA, et al. Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. PLoS Biol 2004, 2(12):e393. 10.1371/journal.pbio.0020393, 526179, 15534693.
59. Mc Clurg P, Pletcher MT, Wiltshire T, Su AI. Comparative analysis of haplotype association mapping algorithms. BMC Bioinformatics 2006, 7:61. 10.1186/1471-2105-7-61, 1409800, 16466585.
60. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 1979, 6:65-70.
61. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289-300.